Heart Health, Cholesterol and Long-Term Mortality

Table of Contents

1. What the Peanut Brings to an Artery
2. Feeding Trials: What Happens to Cholesterol
3. The Pooled Lipid Analysis
4. The Mortality Cohorts
5. The Study That Made This Convincing
6. Cardiovascular Endpoints Specifically
7. PREDIMED, and the Honest Caveat About It
8. Blood Sugar and Type 2 Diabetes
9. The Plausible Mechanisms
10. What the Evidence Does Not Show
11. How Much, in Practice
12. The Version That Ruins It
13. Key Research Papers
14. Connections
15. Featured Videos

What the Peanut Brings to an Artery

About half the weight of a peanut is oil, and its composition is the starting point for everything below.

• Monounsaturated fat, around 24 grams per 100 grams, overwhelmingly oleic acid — the same fatty acid that dominates olive oil and avocado. High-oleic cultivars, now widely grown, push that fraction higher and keep far better on the shelf, because oleic acid is much less prone to oxidation than the polyunsaturated fats. Mozingo and colleagues showed the practical consequence directly: roasted, salted in-shell peanuts made from high-oleic chemistry stayed acceptable far longer than conventional ones.
• Polyunsaturated fat, around 15.6 grams, almost entirely linoleic acid, an omega-6. Peanuts contain essentially no omega-3.
• Saturated fat, around 6.3 grams, mostly palmitic acid.
• No cholesterol and no trans fat in the natural state.
• Phytosterols, roughly 220 milligrams per 100 grams, chiefly beta-sitosterol. These are plant molecules shaped enough like cholesterol to compete with it for absorption in the gut, which is the same principle behind the sterol-fortified spreads sold for cholesterol lowering — at a much lower dose, but present in a whole food rather than a manufactured one.
• Fiber, about 8.5 grams per 100 grams, which binds bile acids and forces the liver to pull cholesterol out of circulation to make more.
• Magnesium and potassium in useful amounts, both relevant to vascular tone and blood pressure.
• Arginine, about 3 grams per 100 grams — peanuts are among the densest ordinary dietary sources of the amino acid the vessel lining uses to make nitric oxide.

The honest complication is the omega-6 point. Linoleic acid is an essential nutrient and there is nothing wrong with it in itself; the argument is about proportion, because industrial seed oils already supply it in quantities far beyond anything humans historically ate. A handful of peanuts contributes a few grams and does not move that balance. Peanut oil used as the household cooking fat every day is a different proposition. The sensible position is to eat peanuts as a food and get the fat balance of the diet elsewhere — olive oil as the default kitchen fat, salmon and sardines for omega-3.

Back to Table of Contents

Feeding Trials: What Happens to Cholesterol

Alper and Mattes ran an eight-week peanut feeding study in healthy adults, published in 2003, and its design is what makes it interesting. Rather than substituting peanuts for something else in a tightly controlled diet — which is how you engineer a favourable lipid result — participants added peanuts on top of their habitual eating. The measured outcome was an improvement in the standard cardiovascular risk indices, with triglycerides falling substantially and total and LDL cholesterol moving in the favourable direction, while HDL was not reduced. Body weight rose far less than the added calories predicted, a finding taken up in detail on the protein and satiety page.

The generalisable point is that the lipid benefit does not depend on a clever substitution. It shows up even when peanuts are simply added, which is how people actually eat them.

Back to Table of Contents

The Pooled Lipid Analysis

The strongest single statement about nuts and blood lipids comes from Sabaté and colleagues, who pooled the primary data from 25 nut-feeding intervention trials, published in Archives of Internal Medicine in 2010. Across those trials, at an average intake of about 67 grams of nuts a day, total cholesterol and LDL cholesterol both fell by a few per cent, the ratio of total to HDL cholesterol improved, and triglycerides fell — with the triglyceride effect concentrated in participants whose triglycerides were high to begin with. Effects were larger in people with higher starting LDL, and larger at higher nut doses.

Three qualifications belong with that result. Sixty-seven grams a day is a large amount, well above a typical serving. The analysis pooled several kinds of nut, so it describes nuts as a class rather than peanuts specifically. And a few per cent off LDL is real but modest — roughly the sort of change a person gets from a meaningful dietary shift, not from a statin. What makes it matter is that it comes free, alongside the fiber, magnesium, niacin and protein, from a food people enjoy.

Back to Table of Contents

The Mortality Cohorts

Lipids are a surrogate. What people want to know is whether nut eaters live longer, and for that you need very large cohorts followed for a very long time.

Bao and colleagues reported in the New England Journal of Medicine in 2013 on roughly 119,000 participants in two long-running US cohorts, followed for up to thirty years. Nut consumption was inversely associated with total mortality in a graded way: the more frequently people ate nuts, the lower their death rate, with those eating nuts seven or more times a week at about a fifth lower risk of dying during follow-up than those who ate none. The association held for cardiovascular death and for cancer death, persisted after adjustment for a long list of dietary and lifestyle factors, and — importantly for this page — was similar for peanuts and for tree nuts.

Aune and colleagues later brought the observational literature together in a dose-response meta-analysis in BMC Medicine, covering millions of person-years. An increment of roughly one serving of nuts a day was associated with substantially lower risk of coronary heart disease, cardiovascular disease overall, and all-cause mortality — reductions in the region of a fifth to a quarter, depending on the endpoint. The curve flattened above about 15 to 20 grams a day, which is a useful practical detail: most of the association is captured by a modest daily amount, not by eating nuts by the bowl.

Back to Table of Contents

The Study That Made This Convincing

Every observational nutrition finding faces the same objection, and it is a good one. In an affluent Western country, the people who eat nuts regularly also tend to exercise more, smoke less, be better educated, be less poor and see a doctor more often. Statistical adjustment can only do so much with that. If nut consumption is simply a marker for a comfortable, health-conscious life, the association will appear whether or not nuts do anything.

Luu and colleagues addressed this directly, in an analysis published in JAMA Internal Medicine in 2015 that pooled three cohorts chosen for how different they were:

• the Southern Community Cohort Study, which deliberately recruited a low-income population in the American South, about two-thirds African American, largely through community health centres;
• the Shanghai Women's Health Study;
• the Shanghai Men's Health Study.

Together these covered more than 200,000 people whose diets, incomes, health systems and disease patterns had almost nothing in common. In the American cohort, peanuts are the overwhelmingly dominant nut and are eaten because they are cheap. In the Shanghai cohorts, peanuts are a staple ingredient of the cuisine. In all three, higher peanut consumption was associated with lower total mortality — reductions in the region of a fifth comparing the highest intake category with the lowest — with the association strongest for cardiovascular death.

That consistency across populations sharing nothing but the food is the part that carries weight. The confounding structure in rural Shanghai in the 1990s is not the confounding structure of low-income Alabama, and a spurious association would not be expected to survive the change intact. It does not make the finding causal. It makes the most obvious alternative explanation considerably harder to sustain.

Back to Table of Contents

Cardiovascular Endpoints Specifically

Guasch-Ferré and colleagues published an analysis in the Journal of the American College of Cardiology in 2017 that separated the nut types, which is exactly what a peanut page needs. Across three large US cohorts, higher total nut intake was associated with lower cardiovascular disease and lower coronary heart disease. Looking at peanuts on their own, eating them two or more times a week was associated with a cardiovascular risk lower by roughly an eighth relative to eating none. Walnuts, unusually rich in the plant omega-3 alpha-linolenic acid, showed a somewhat stronger association than other nuts — a reminder that walnuts are not interchangeable with peanuts.

Becerra-Tomás and colleagues carried out a systematic review and dose-response meta-analysis of prospective studies on nut consumption and cardiovascular incidence and mortality, published in Nutrition Reviews in 2019, reaching consistent conclusions with a formal grading of the evidence quality.

Liu and colleagues asked the question in a group with more to lose: people who already had type 2 diabetes. Reporting in Circulation Research in 2019, they found that among participants with diabetes, higher nut consumption — and particularly increasing nut intake after the diagnosis — was associated with lower cardiovascular disease incidence and lower cardiovascular and all-cause mortality. The observational caveats apply as always, but the direction is the same in the population where cardiovascular risk is highest.

Back to Table of Contents

PREDIMED, and the Honest Caveat About It

PREDIMED is the largest randomised dietary trial ever run on cardiovascular endpoints, and it is routinely cited in support of nuts. It deserves to be, and it also needs a caveat that is usually left out.

The trial assigned participants at high cardiovascular risk to one of three diets: a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with mixed nuts, or a control diet with advice to reduce fat. Both Mediterranean arms showed a markedly lower rate of major cardiovascular events — myocardial infarction, stroke and cardiovascular death — than the control arm. The trial was retracted and republished in the New England Journal of Medicine in 2018 after irregularities in randomisation at some sites were identified; the authors reanalysed the data with those participants handled appropriately and the principal findings were essentially unchanged. That republication is the version to cite, and the episode is a reasonable advertisement for how correction is supposed to work.

The caveat: the nut supplement in PREDIMED was tree nuts. Participants in that arm received a daily 30-gram mixture of walnuts, almonds and hazelnuts. Peanuts were not the intervention. So PREDIMED is powerful evidence that a Mediterranean pattern including a daily handful of nuts reduces cardiovascular events; it is not direct evidence about peanuts. The case for peanuts rests on the cohort studies above, which do separate them, together with the feeding trials showing that peanuts move the same intermediate markers in the same direction.

This is worth saying plainly because the reverse claim — “a randomised trial proved peanuts prevent heart attacks” — is common and is not true.

Back to Table of Contents

Blood Sugar and Type 2 Diabetes

Peanuts have a very low glycemic index — there is little available carbohydrate, and the fat and protein slow gastric emptying — and adding them to a carbohydrate-containing meal measurably flattens that meal's glucose rise.

Jiang and colleagues reported in JAMA in 2002 on a large cohort of US women followed for sixteen years. Frequent nut consumption — five or more times a week — was associated with a substantially lower risk of developing type 2 diabetes, on the order of a quarter lower than in women who rarely ate nuts. Peanut butter eaten five or more times a week showed a similar association, somewhat smaller. Both associations persisted after adjustment for body mass index, physical activity and other dietary factors, which matters because the obvious objection — that thin, active people eat more nuts — is precisely what that adjustment addresses.

The mechanism candidates are the same ones as for the lipid findings, plus two more specific to glucose: magnesium, whose intake is inversely associated with diabetes risk across many cohorts, and the displacement effect — a handful of peanuts eaten as a snack is a handful of something else not eaten, and in most diets that something else is refined carbohydrate.

See type 2 diabetes, insulin resistance and metabolic syndrome.

Back to Table of Contents

The Plausible Mechanisms

No single component explains the findings, and it would be surprising if one did. The candidates that are all probably partly true:

1. Fatty acid substitution. Oleic acid replacing saturated fat in circulating lipoproteins improves the LDL picture. This is the oldest and best-established mechanism in nutrition and it applies straightforwardly here.
2. Phytosterols. Beta-sitosterol and its relatives compete with cholesterol for uptake in the intestine, reducing net absorption.
3. Fiber. Binds bile acids in the gut; the liver replaces them using cholesterol, which lowers the circulating pool. Fiber also slows glucose absorption and feeds the gut microbiome — see gut health.
4. Arginine and nitric oxide. The vessel lining converts arginine to nitric oxide, which relaxes the vessel wall. Impaired nitric oxide production is one of the earliest measurable abnormalities in arterial disease. Peanuts are among the densest common sources of arginine, though nobody has demonstrated that peanut arginine specifically produces the cohort findings.
5. Magnesium and potassium. Both are involved in vascular smooth-muscle tone and blood pressure regulation, and both are under-consumed in typical diets.
6. Vitamin E and the phenolics. Alpha-tocopherol protects circulating lipoproteins from oxidation; the peanut's phenolic acids and the proanthocyanidins concentrated in its red skin add to measured antioxidant capacity. Whether that translates into a clinical effect is unproven, and antioxidant supplement trials have generally disappointed — which is an argument for the food, not the capsule.
7. Displacement. The least glamorous and possibly the largest. What a handful of peanuts most often replaces is crisps, biscuits or nothing-followed-by-overeating.

Back to Table of Contents

What the Evidence Does Not Show

Being clear about the limits is what makes the rest of the page trustworthy.

• No randomised trial has tested peanuts against hard cardiovascular endpoints. The endpoint trial is PREDIMED and it used tree nuts. Everything about peanuts and heart attacks is either observational or based on intermediate markers.
• Observational studies cannot establish causation. They can be adjusted, replicated across dissimilar populations and checked for dose-response — all of which has been done here, and all of which strengthens the case — but they remain observational.
• Most cohorts group peanuts with tree nuts. Where they have been separated, peanuts have generally behaved like tree nuts; but the peanut-specific estimates rest on fewer studies.
• The effect sizes on lipids are modest. A few per cent off LDL is not a treatment for established familial hypercholesterolaemia and should not be presented as one.
• Nobody has shown that more is better. The dose-response curves flatten at moderate intakes. There is no evidence that five handfuls a day does five times as much good, and good reason to think the calories eventually assert themselves.
• Resveratrol is a footnote, not a mechanism. Peanuts genuinely contain it, at micrograms per serving; the trials that generated the headlines used hundreds of milligrams. See resveratrol for the full accounting.

Back to Table of Contents

How Much, in Practice

The intakes associated with benefit are not large, which is the most useful thing on this page.

• A standard serving is 28 to 30 grams — a small closed handful, about 28 to 30 kernels, roughly 160 calories, 7 grams of protein, 2.4 grams of fiber and about 48 milligrams of magnesium. Two level tablespoons of peanut butter is comparable.
• The mortality associations appear at five or more servings a week. The cardiovascular associations for peanuts specifically appear at two or more servings a week. Both are within reach of anybody.
• The dose-response flattens around 15 to 20 grams a day. Half a handful daily captures most of what the data describe.
• Eat them with or before a meal rather than grazing. A measured portion in a bowl beats an open bag beside a screen, which is the single most reliable way to eat 400 calories of peanuts without noticing.

Two adjustments worth making. If blood pressure is a concern, buy unsalted and add your own salt if you want it — plain peanuts carry 18 milligrams of sodium per 100 grams, heavily salted ones several hundred, and salting them yourself invariably means less. And if you have advanced kidney disease, peanuts are high in both potassium and phosphorus and the portion decision belongs to a renal dietitian.

Back to Table of Contents

The Version That Ruins It

Everything above describes plain peanuts and plain peanut butter. No cohort study has shown a benefit for honey-roasted peanuts, chocolate-coated peanuts, peanut brittle, or peanut butter built on added sugar and hydrogenated oil. Those are different foods that happen to contain peanuts, and treating the evidence as though it transfers to them is the most common error made with this literature.

The rules are short:

1. Read the peanut butter label and expect peanuts, possibly salt, and nothing else. Skip anything with hydrogenated or partially hydrogenated oil, palm oil added as a stabiliser, added sugar or corn syrup. Natural peanut butter separates because there is nothing in it to stop the oil rising — that is the point, not a defect. Stir it once and keep the jar upside down between uses.
2. Buy unsalted or lightly salted whole peanuts and roast them yourself if you want more flavour. Fifteen to twenty minutes at about 175 °C in a single layer, no oil needed — peanuts roast in their own fat.
3. Skin-on beats blanched where the source is trustworthy: the papery red skin is one of the richest food sources of proanthocyanidins, the condensed tannins Lou and colleagues characterised.
4. Never choose a reduced-fat peanut butter. The fat is most of the reason peanuts do what they do, and what replaces it is starch and sugar.
5. Use peanut oil sparingly. It has a high smoke point and is genuinely useful for occasional high-heat cooking, but as a daily cooking fat it delivers linoleic acid in quantities a handful of peanuts never would. Olive oil is the better default.

Full buying, storing and cooking detail is on the main peanuts page, and the peanut butter question is treated at length under protein, satiety and peanut butter.

Back to Table of Contents

Key Research Papers

1. Luu HN, Blot WJ, Xiang YB, Cai H, Hargreaves MK, Li H, et al. Prospective evaluation of the association of nut/peanut consumption with total and cause-specific mortality. JAMA Internal Medicine. 2015;175(5):755-766. — doi:10.1001/jamainternmed.2014.8347
2. Bao Y, Han J, Hu FB, Giovannucci EL, Stampfer MJ, Willett WC, et al. Association of nut consumption with total and cause-specific mortality. New England Journal of Medicine. 2013;369(21):2001-2011. — doi:10.1056/NEJMoa1307352
3. Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts (PREDIMED). New England Journal of Medicine. 2018;378(25):e34. — doi:10.1056/NEJMoa1800389
4. Guasch-Ferré M, Liu X, Malik VS, Sun Q, Willett WC, Manson JE, et al. Nut consumption and risk of cardiovascular disease. Journal of the American College of Cardiology. 2017;70(20):2519-2532. — doi:10.1016/j.jacc.2017.09.035
5. Sabaté J, et al. Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Archives of Internal Medicine. 2010;170(9):821-827. — doi:10.1001/archinternmed.2010.79
6. Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, et al. Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies. BMC Medicine. 2016;14:207. — doi:10.1186/s12916-016-0730-3
7. Becerra-Tomás N, Paz-Graniel I, Kendall CWC, Kahleova H, Rahelić D, Sievenpiper JL, et al. Nut consumption and incidence of cardiovascular diseases and cardiovascular disease mortality: a meta-analysis of prospective cohort studies. Nutrition Reviews. 2019;77(10):691-709. — doi:10.1093/nutrit/nuz042
8. Liu G, Guasch-Ferré M, Hu Y, Li Y, Hu FB, Rimm EB, et al. Nut consumption in relation to cardiovascular disease incidence and mortality among patients with diabetes mellitus. Circulation Research. 2019;124(6):920-929. — doi:10.1161/CIRCRESAHA.118.314316
9. Jiang R, et al. Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA. 2002;288(20):2554-2560. — doi:10.1001/jama.288.20.2554
10. Alper CM, Mattes RD. Peanut consumption improves indices of cardiovascular disease risk in healthy adults. Journal of the American College of Nutrition. 2003;22(2):133-141. — doi:10.1080/07315724.2003.10719286
11. Lou H, et al. A-type proanthocyanidins from peanut skins. Phytochemistry. 1999;51(2):297-308. — doi:10.1016/S0031-9422(98)00736-5
12. Mozingo RW, O'Keefe SF, Sanders TH, Hendrix KW. Improving shelf life of roasted and salted inshell peanuts using high oleic fatty acid chemistry. Peanut Science. 2004;31(1):40-45. — doi:10.3146/pnut.31.1.0009

Live PubMed Searches

1. PubMed: peanut consumption and cardiovascular disease
2. PubMed: nuts and blood lipids in randomised trials
3. PubMed: peanuts, glycemic response and type 2 diabetes
4. PubMed: arginine, nitric oxide and endothelial function

Back to Table of Contents

Connections

• Peanuts — the main topic page
• Peanuts — Benefits Deep Dive — the hub for these four articles
• Peanuts: Nutrient Profile — the full composition table
• Walnuts — the one common nut with real omega-3
• Almonds — the tree-nut comparison
• Olive Oil — the other great oleic-acid food
• Cardiology — the cardiovascular section
• Atherosclerosis — what the lipid findings are ultimately about
• Type 2 Diabetes — the glucose evidence in context
• Lipid Panel — how to read the numbers these trials moved
• Arginine — the nitric oxide precursor peanuts are rich in
• Resveratrol — honestly measured in peanuts

Back to Table of Contents

Featured Videos